Acute myeloid leukemia following long-term chemotherapy with pemetrexed for non-small cell lung carcinoma
Tomohiro Tanakaa Koichiro Nozakib Hikaru Mamizua Takeshi Ohtaa Toshiki Furukawaa Takashi Ishidaa
aDepartment of Internal Medicine, Niigata Prefectural Hospital
bDepartment of Internal Medicine, Niigata Cancer Hospital
We report a case of a 77-year-old male who presented with a metastatic pulmonary adenocarcinoma. The patient was administered a carboplatin and gemcitabine regimen. After a year, a loco-reginal relapse was revealed. Treatment with pemetrexed was used and achieved partial response. After 65 cycles of chemotherapy, the patient underwent complaints of general fatigue. A laboratory test revealed pancytopenia. Though we treated it with G-CSF many times, the pancytopenia made no improvement. Bone marrow aspiration biopsy confirmed a diagnosis of acute myeloid leukemia. The cytogenetic study revealed 11q23. Here we reported a case of acute myeloid leukemia after long-term treatment by pemetrexed.
Pemetrexed Secondary leukemia Secondary cancer
Received 19 Apr 2017 / Accepted 4 Jul 2017
AJRS, 6(5): 351-354, 2017